These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6697959)

  • 21. Vesicular release of prolactin from preformed prolactin granules is stimulated by soluble factor(s) from the anterior pituitary of lactating rats.
    Huerta-Ocampo I; Fiordelisio T; Díaz N; Navarro N; Castilla A; Cárabez A; Aguilar MB; Morales T; Hernández-Cruz A; Mena F
    Neuroendocrinology; 2007; 85(1):1-15. PubMed ID: 17341846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine inhibits prolactin release when cyclic adenosine 3',5'-monophosphate levels are elevated.
    Delbeke D; Scammell JG; Martinez-Campos A; Dannies PS
    Endocrinology; 1986 Apr; 118(4):1271-7. PubMed ID: 3004906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rosiglitazone, PPAR-gamma receptor ligand, decreases the viability of rat prolactin-secreting pituitary tumor cells in vitro.
    Gruszka A; Kunert-Radek J; Pawlikowski M
    Neuro Endocrinol Lett; 2005 Feb; 26(1):51-4. PubMed ID: 15726020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin and 17 beta-estradiol increase the intracellular prolactin content of GH4C1 cells.
    Kiino DR; Dannies PS
    Endocrinology; 1981 Oct; 109(4):1264-9. PubMed ID: 7026222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells.
    Hofland LJ; van Koetsveld PM; Wouters N; Waaijers M; Reubi JC; Lamberts SW
    Endocrinology; 1992 Aug; 131(2):571-7. PubMed ID: 1322274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of cysteamine induction of the 22K prolactin variant in the rat pituitary.
    Anthony PK; Powers CA
    Neuroendocrinology; 1993 Jan; 57(1):167-76. PubMed ID: 8479612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of galanin gene expression in the rat anterior pituitary gland by the somatostatin analog SMS 201-995.
    Hyde JF; Howard G
    Endocrinology; 1992 Nov; 131(5):2097-102. PubMed ID: 1385097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of thyrotropin-releasing hormone on prolactin compartments in clonal rat pituitary tumor cells.
    Morin A; Rosenbaum E; Tixier-Vidal A
    Endocrinology; 1984 Dec; 115(6):2271-7. PubMed ID: 6437794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical and ultrastructural studies on estrogen-induced pituitary tumors in F344 rats.
    De Nicola AF; von Lawzewitsch I; Kaplan SE; Libertun C
    J Natl Cancer Inst; 1978 Sep; 61(3):753-63. PubMed ID: 278852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of cysteamine on the lysosomal enzymes of the hyperprolactinaemic rat pituitary.
    Jeitner TM; Oliver JR
    J Endocrinol; 1990 Apr; 125(1):75-80. PubMed ID: 2110966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cysteamine: a potent and specific depletor of pituitary prolactin.
    Millard WJ; Sagar SM; Landis DM; Martin JB
    Science; 1982 Jul; 217(4558):452-4. PubMed ID: 7089575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats.
    Winneker RC; Parsons JA
    Cancer Res; 1981 May; 41(5):1772-7. PubMed ID: 7214344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High concentrations of bisphenol A induce cell growth and prolactin secretion in an estrogen-responsive pituitary tumor cell line.
    Chun TY; Gorski J
    Toxicol Appl Pharmacol; 2000 Feb; 162(3):161-5. PubMed ID: 10652244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypophysectomized rats depend on residual prolactin for survival.
    Nagy E; Berczi I
    Endocrinology; 1991 Jun; 128(6):2776-84. PubMed ID: 2036962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-prolactin cell-surface immunoreactivity identifies a subpopulation of lactotrophs from the rat anterior pituitary.
    St John PA; Dufy-Barbe L; Barker JL
    Endocrinology; 1986 Dec; 119(6):2783-95. PubMed ID: 3536448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of thalidomide on the growth, secretory function and angiogenesis of estrogen-induced prolactinoma in Fischer 344 rats.
    Stepień H; Lawnicka H; Mucha S; Wagrowska-Danilewicz M; Stepień B; Siejka A; Komorowski J
    Life Sci; 2006 Sep; 79(18):1741-8. PubMed ID: 16846617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pantethine, a cysteamine precursor, depletes immunoreactive somatostatin and prolactin in the rat.
    Reichlin S; Bollinger-Gruber JA
    Endocrinology; 1985 Aug; 117(2):492-5. PubMed ID: 2862009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tripeptide aldehyde protease inhibitors may depress in vitro prolactin and growth hormone release.
    Nagy I; Makara GB; Horváth G; Rappay G; Kurcz M; Bajusz S
    Endocrinology; 1985 Apr; 116(4):1426-32. PubMed ID: 3971921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cysteamine, zinc, and thiols modify detectability of rat pituitary prolactin: a comparison with effects on bovine prolactin suggests differences in hormone storage.
    Jacobs LS; Lorenson MY
    Metabolism; 1986 Mar; 35(3):209-15. PubMed ID: 3081777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preferential release of newly synthesized prolactin granules is the result of functional heterogeneity among mammotrophs.
    Walker AM; Farquhar MG
    Endocrinology; 1980 Oct; 107(4):1095-104. PubMed ID: 6773746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.